{
	"symbol": "RVX",
	"name": "Resverlogix Corp.",
	"price": 0.05,
	"priceChange": 0,
	"percentChange": 0,
	"exchangeName": "Toronto Stock Exchange",
	"exShortName": "TSX",
	"exchangeCode": "TSX",
	"marketPlace": null,
	"sector": "Healthcare",
	"industry": "Biotechnology",
	"volume": 93500,
	"openPrice": 0.05,
	"dayHigh": 0.05,
	"dayLow": 0.045,
	"MarketCap": 14215695,
	"MarketCapAllClasses": 14213195,
	"peRatio": "",
	"prevClose": 0.05,
	"dividendFrequency": null,
	"dividendYield": null,
	"dividendAmount": null,
	"dividendCurrency": null,
	"beta": 0.609854,
	"eps": null,
	"exDividendDate": "",
	"longDescription": "Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.",
	"fulldescription": "Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.",
	"website": "https://www.resverlogix.com",
	"email": "sarah@resverlogix.com",
	"phoneNumber": "+1 403 254-9252",
	"fullAddress": "4820 Richard Road S.W,Suite 300, Calgary, AB, CA",
	"employees": "18",
	"shareOutStanding": 284313894,
	"totalDebtToEquity": "",
	"totalSharesOutStanding": 284263894,
	"sharesESCROW": null,
	"vwap": 0.049946236,
	"dividendPayDate": null,
	"weeks52high": 0.095,
	"weeks52low": 0.035,
	"alpha": -0.03683,
	"averageVolume10D": 155371,
	"averageVolume20D": 118914,
	"averageVolume30D": 92803,
	"averageVolume50D": 75979,
	"priceToBook": -0.12,
	"priceToCashFlow": -2.8,
	"returnOnEquity": "",
	"returnOnAssets": -363.67,
	"day21MovingAvg": 0.041429,
	"day50MovingAvg": 0.0422,
	"day200MovingAvg": 0.05055,
	"dividend3Years": "",
	"dividend5Years": "",
	"datatype": "equity",
	"issueType": "CS",
	"close": 0.05,
	"qmdescription": "Biotechnology",
	"__typename": "Company"
}